key: cord-1030331-abczojy8 authors: Talmor, Guy; Grube, Jordon G.; Eloy, Jean Anderson; Liu, James K.; Hsueh, Wayne D. title: Nasoseptal Flap Necrosis After Endoscopic Skull Base Surgery in the Setting of SARS-CoV-2/COVID-19 date: 2020-05-29 journal: World Neurosurg DOI: 10.1016/j.wneu.2020.05.237 sha: 61e1c3a7b20ee364886ac7c4147c9cd3e84ddc6b doc_id: 1030331 cord_uid: abczojy8 ABSTRACT Background A novel viral strain known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created a worldwide pandemic known as Coronavirus 2019 (COVID-19). Early reports from China highlighted the risks associated with performing endoscopic endonasal skull base surgery in patients with SARS-CoV-2. We present a rare complication of nasoseptal flap (NSF) necrosis associated with COVID-19, further emphasizing the challenges of performing these procedures in this era. Case Description A 78-year-old male underwent an extended endoscopic endonasal transplanum resection of a pituitary macroadenoma for decompression of the optic chiasm. The resulting skull base defect was repaired using a pedicled nasoseptal flap (NSF). The patient developed meningitis and a cerebrospinal fluid (CSF) leak on post-operative day thirteen requiring revision repair of the defect. Twelve days later, he developed persistent fevers and rhinorrhea. The patient was re-explored endoscopically, and the NSF was noted to be necrotic and devitalized with evident CSF leakage. At that time, the patient tested positive for Sars-CoV-2. Post-operatively, he developed acute respiratory distress syndrome complicated by hypoxic respiratory failure and death. Conclusion To our knowledge, this is the first reported case of NSF necrosis in a patient with COVID-19. We postulate that the thrombotic complications of COVID-19 may have contributed to vascular pedicle thrombosis and NSF necrosis. Although the pathophysiology of SARS-CoV-2 and its effect on the nasal tissues is still being elucidated, this case highlights some challenges of performing endoscopic skull base surgery in the era of COVID-19. Beginning in December of 2019, severe cases of pneumonia were reported in Wuhan, China. These cases were linked to a novel coronavirus strain related to severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). This novel strain, now known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has since spread globally, resulting in the Coronavirus 2019 (COVID-19) pandemic. A declaration of a public health emergency of international concern was further issued by the World Health Organization in March 2020. [1] Over 4 million cases of COVID-19 have been reported worldwide to date. [2] Clinical observations of COVID-19 indicate a viral syndrome which ranges in severity from asymptomatic infection to acute respiratory failure and death. Common clinical manifestations include fever, cough, rhinorrhea, dyspnea, and hypoxia. [3] Previous research during the initial SARS epidemic in 2004 identified the functional receptor for SARS-CoV-1 to be angiotensin-converting enzyme 2 (ACE2) receptor. This receptor is present on pneumocytes and was thought to be the initial site of entry for SARS-CoV-1. [4] [5] SARS-CoV-2 similarly binds ACE2 receptors. However, this binding occurs at a higher affinity than SARS-CoV-1. [6] A recent study found that ACE2 mRNA is expressed in nasal epithelial cells at a level similar to that of type 2 pneumocytes, with high concentrations of SARS-CoV-2 DNA found on nasal swabs. [7] This suggests a high level of viral uptake by nasal epithelial cells. As such, nasopharyngeal swab is currently the accepted sampling method for nucleic acid amplification testing to diagnose COVID-19 infection. [8] The clinical significance of the ACE2 receptor presence in nasal epithelium remains poorly understood, but may have ramifications with regards to endonasal surgery. Early in the COVID-19 pandemic, endoscopic endonasal procedures were identified as significantly high-risk. According to an unpublished report of endoscopic endonasal skull base surgery performed in Wuhan, 14 care team members developed symptoms of COVID-19 after endoscopic endonasal transsphenoidal resection in an affected patient. [9] Moreover, anosmia has been recognized as a significant symptom of COVID-19 infection. [10] Preliminary reports suggest that ACE2 receptors are present in olfactory support and stem cells. Therefore, the presence of anosmia may be secondary to direct viral involvement of nasal olfactory epithelium. The patient is a 78-year-old male with a prior history of gastric cancer who initially presented with progressive bitemporal hemianopsia. Magnetic resonance imaging (MRI) of the pituitary was notable for a sellar/suprasellar mass consistent with a pituitary macroadenoma with anterior extension over the planum sphenoidale, measuring 3.4 x 2.9 x 3.0 cm. The lesion extended to the suprasellar region and cavernous sinus, compressing the optic chiasm. The patient underwent endoscopic endonasal resection via an extended transplanum transtuberculum approach. Intraoperatively, a high-flow CSF leak was noted. The resulting skull base defect was repaired with a multi-layer closure, utilizing two layers of autologous fascia lata graft and a right-sided pedicled NSF. Surgicel (Ethicon Inc, Somerville, NJ, USA) and Gelfoam (Pfizer Inc, New York, NY, USA) were used to further bolster the repair followed by a Merocel pack, with no residual CSF leak noted. The patient's immediate post-operative course was uncomplicated and lumbar drainage was used for 5 days after surgery. Post-operative MRI confirmed a gross total resection. No CSF leak was clinically observed, and the patient was discharged home on post-operative day (POD) 7. Six days after discharge, the patient presented to the emergency room with fevers and persistent rhinorrhea. Computed tomography (CT) was notable for worsening pneumocephalus. Lumbar puncture and CSF studies revealed rare gram-negative coccobacilli and over 1,000 white blood cells. The patient was admitted and treated empirically for bacterial meningitis with vancomycin and ceftazidime. The patient was taken immediately to the operating room to inspect and revise the repair. Intraoperatively, CSF leakage was noted underneath a viable NSF along the left lateral aspect of the skull base defect. The defect was reconstructed with fascia lata, adipose tissue, and the original viable NSF was repositioned and replaced over the skull base defect. Postoperative lumbar drainage was used for about 7 days. The patient was persistently febrile for three days after the operation, requiring continued treatment with intravenous antibiotics. Repeat CSF cultures were negative and no further CSF leakage was noted. The patient improved clinically and remained afebrile. On POD 25, the patient developed recurrent fever with hypoxia and rhinorrhea. The patient was once again taken to the operating room to endoscopically explore the skull base for recurrent CSF leak. Prior to surgery, the patient was tested for COVID-19 which was determined to be positive the following day. Intraoperatively, the right-sided NSF was now noted to be necrotic and devitalized. This was excised and a new contralateral left-sided NSF was elevated and placed over the repair site until no further leak was observed. The initial devitalized flap and contralateral NSF are shown in Figures 1 and 2 . No empyema was found at the surgical site and repeated CSF cultures remained negative. Postoperatively, he was started on azithromycin and hydroxychloroquine for COVID-19. The patient remained febrile with increasing oxygen demand. The patient was persistently agitated and hypotensive. Chest radiography and serial arterial blood gas tests indicated progression of acute respiratory distress syndrome. The patient subsequently passed away on POD 3 due to acute hypoxic respiratory failure in setting of COVID-19. The NSF is considered the workhorse flap for reconstruction of skull base defects following endoscopic endonasal surgery. [12] As the NSF has become more commonly utilized, the reported rate of post-operative CSF leaks in large skull base defects has declined from 50% to less than 5%. [13] [14] [15] [16] [17] Complication rates of the NSF are low and include mucocele formation, septal perforation, olfactory loss and nasal dorsum collapse. [17] Flap necrosis is a particularly rare complication. A single-institution review of 601 NSF's found a necrosis rate of 1.3% on reexploration. [12] Similar studies found a 0% incidence of NSF necrosis among their patient populations. [18] [19] [20] The reported cases of NSF necrosis described in the literature have found that patients usually presented with signs of meningitis at least 1 week after endoscopic skull base surgery, and that 50% developed an empyema at the surgical site. [17] The patient in this report developed signs and symptoms of meningitis later in his postoperative course, with initial fever onset occurring on POD 11. Re-exploration and CSF leak repair initially took place on POD 13 with the NSF found to be intact and viable at the time. Lumbar puncture was positive for bacterial meningitis, and the patient responded well to antibiotic therapy. He was afebrile with no clinical evidence of a CSF leak for several days before his symptoms recurred on POD 25. It was only upon subsequent re-exploration that the NSF was found to be necrotic with persistent CSF leakage. Pertinently, SARS-CoV-2 testing performed on that day was positive. No empyema was found at the surgical site and repeat CSF cultures were negative at that time. Interestingly, the diagnosis of NSF necrosis coincided with the onset of clinical manifestations of COVID-19. Research efforts to characterize the pathogenesis of SARS-CoV-2 and viral entry into nasal epithelium are ongoing. Preliminary reports indicate the presence of ACE2 in nasal epithelium, which is the functional receptor for SARS-CoV-2. The clinical significance of this finding remains unclear, although it has been hypothesized that the presence of ACE2 receptors in nasal epithelium is the underlying reason for the high incidence of anosmia reported in COVID-19 infection. [11] Additionally, it has also been previously noted that there are derangements in coagulation profiles of patients with COVID-19, resulting in hypercoagulation, venous and arterial thrombosis, and thromboembolic disease. [21] [22] [23] Recent studies have reported cases of myocardial infarction, ischemic stroke, and cerebral venous thrombosis. [23] [24] [25] Giacomelli et al. recently described a case of acute thrombosis of an aortic prosthetic graft in a patient with severe COVID-19 related pneumonia resulting in bilateral acute limb ischemia. [26] This may suggest that our NSF necrosis may possibly be due to a thrombotic event in the vascular pedicle of the NSF, although the significance and pathophysiology of thrombotic angiopathies are still being elucidated. Until a direct mechanism of damage at the cellular level is uncovered, it is unclear what role SARS-CoV-2 infection played in this patient's NSF necrosis. Nonetheless, our case highlights that the COVID-19 pandemic may increase the complication rates observed in endonasal endoscopic skull base surgery. This is supported by a recent retrospective review from Wuhan, China which examined 34 asymptomatic patients with COVID-19 who underwent surgery during the incubation period. 44% of these patients subsequently required ICU admission for respiratory deterioration with a noted mortality rate of 20.5%. [27] For these reasons, along with the increased risk of transmission to providers performing endonasal skull base surgery, we recommend deferring non-essential endoscopic endonasal skull base procedures at this time, especially those that require removal of bone with a high-speed drill. In emergent cases, pre-operative SARS-CoV-2 testing is indicated to further stratify patients for surgery and anticipate complications post-operatively. 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak -United States The COVID-19 epidemic Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV Laboratory diagnosis of emerging human coronavirus infections -the state of the art Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Non-neural expression of SARS CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients Nasoseptal flap necrosis: a rare complication of endoscopic endonasal surgery Endoscopic reconstruction of the cranial base using a pedicled nasoseptal flap Surgical nuances for nasoseptal flap reconstruction of cranial base defects with high-flow cerebrospinal fluid leaks after endoscopic skull base surgery Long-term effectiveness of a reconstructive protocol using the nasoseptal flap after endoscopic skull base surgery Nasoseptal flap reconstruction of high flow intraoperative cerebral spinal fluid leaks during endoscopic skull base surgery Complications of Nasoseptal Flap Reconstruction: A Systematic Review Long-term olfactory outcome after nasoseptal flap reconstructions in midline skull base surgery Complications associated with the pedicled nasoseptal flap for skull base reconstruction Endoscopic skull base reconstruction: a review and clinical case series of 152 vascularized flaps used for surgical skull base defects in the setting of intraoperative cerebrospinal fluid leak Prominent changes in blood coagulation of patients with SARS-CoV-2 infection COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19 Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke Acute thrombosis of an aortic prosthetic graft in a patient with severe COVID-19 related pneumonia Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection